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SYNTHESIS AND CHEMISTRY OF NAPHTHALENE ANNULATED
TRIENYL IRON COMPLEXES: POTENTIAL ANTICANCER DNA
ALKYLATION REAGENTS

Traci Means
Department of Chemistry and Bioc~emistry
Fulbright College of Arts and Sctences
Mentor: Dr. Neil T. Allison
Department of Chemistry and Biochemistry

Abstract:
Iron complex chemistry that opens a new door to the
medicinal and pharmaceutical worlds is the aim ofthis research.
Specifically, ortho-quinone methide moieties are intermediates
in several antitumor drugs and have been identified as
bioreductive alkylators ofDNA. In our research, a class of iron
compounds has been targeted to resemble these quinone methides.
It is hoped that these new compounds could be modified to
provide a window of opportunity toward the discovery of a
selective mode of drug delivery. We have focused our efforts on
generating a reactive transition metal complexed 5-membered
ring analog of o-quinone methide based on our earlier reports
of CpFe(CO)z(butadienyl) complexes. In this vein, we have
elaborated this chemistry by preparing and reacting a
lithionaphthalene allene with CpFe( CO) j. which gave the desired
naphthalene annulated sigma complex. This complex thermally
rearranged to the desired naphthalene annulated 5-membered
ring quinone methide analog. Upon photolysis, this complex
successfully mimicked its antecedent and alkylated alcohols.
Tluts, we here report our initial study of the preparation and
chemistry of a transition metal complexed 5-membered ring
quinone methide analog. Its reactions with alcohols have
accomplished the first step toward the ultimate goal ofselectively
alf...')·lating DNA.

Introduction:
Cancer has become a prevalent disease facing many people
of the world today. Naturally, its ubiquitous and devastating
character has led many attempts to synthesize a suitable drug for
combat. Fortunately, scientists have determined the benevolent
nature of quinone methides and their alk-ylation of nucleic acids
as an effective mechanism for anticancer antibiotics. Orthoquinone methide moieties are believed to be intermediates of
several antitumor drugs.
Quinone methides are a class of compounds in which one
of the oxygen atoms of a quinone is replaced by a methylene (or
substituted methylene) group. The reactivity of quinone methides
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is mainly electrophilic in nature, which can also be directly
correlated to their toxicological properties. If the alkylation
process is achieved under mild, ideally biological, conditions, it
could be used in a number ofbiomolecular applications. In fact,
these reactive intermediates have been used as DNA alkylating
agents and crosslinkers. 1 Compounds that react through quinone
methide and related intermediates moieties couple to the amino
groups of guanine (Nl) and adenine (N6) bases primarily to
modify nitrogen nucleophiles; they also couple to the oxygen
functional groups, most notably the phosphate and ribose oxygens
as well as (02) of cytosine and (06) of guanine. The specificity
of DNA alkylation depends greatly on the reaction pathway and
the ability of the reactive intermediate to associate with particular
nucleotide sequences or helical confrrmations. 2
As to the nature of quinone methides, they, especially the
simple ones, are unstable and are often not isolable in a pure
form. Instead, they rapidly polymerize upon concentration of
their dilute solutions. So far, no "simple" quinone methide has
been isolated, except for cases in which the quinone methide
moiety is part of a fused aromatic system with little contribution
from the quinone methide form. The observed stability of such
a complex could only be attributed to the formation of a strong
metal-olefin bond that remains stable even at the expense of the
loss of aromaticity of the quinone methide. 3 Therefore, the key
to synthesizing these intramolecular metal-quinone methide
complexes is to retain the reactive nature of the quinone methide
complexes so that it can subsequently interact and modify
reagents, such as DNA.
The marriage of organometallic chemistry and drug design
has only lightly been explored.4 Recently, the Allison group has
targeted a class of organometallic compounds that resembles
quinone methides and may possess potential DNA alkylation
abilities. Specifically, we chose a research pathway (shown in
Figure 1) that would focus on the preparation and chemistry of
a selected (h 1-C 5H5)Fe(C0) 2-(h 1-pentatrienyl) complex that
should mimic new medicines.5
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In efforts to synthesize these compounds, previous studies
of the Allison group found that in general, butadienyl iron
complexes converted to hydroxyferrocenones in very high yields
as outlined in Schemel.6•7 The synthesis of the starting butadienyl
complexes 2 was carried out with ease; yet, in the past, efforts to
prepare compounds needed for our project, i.e. the analogous
pentatrienyl sigma complex, had not been successful. (See
Scheme 2.) The reason for this failure was thought to be due to
an intermediate 4 in the mechanism that gives complex 5. This
mechanism is shown in Scheme 3, in which pentatrienyllithium
attacks the carbonyl to form 4, followed by concomitant alkyl
migration and iodide displacement to give 5.
We suspected that intermediate 4 was responsible for
previous stumbling blocks in preparation of the pentatrienyl
complex. Instead of the pathway shown in Scheme 3, it was
thought that the intermediate underwent cyclization to give an
undesired complex 6 and ultimately decomposed as shown in
Scheme4.
We carried out model theoretical calculations for an organic
compound that corresponded to 4 and found that the conversion
of 4 to 6 was favorable by -20kcallmol. This estimate related the
ease of the undesired cyclization to occur, followed by
decomposition. In light of this problem, we sought a pentatrienyl
ligand that contained a key annulated aromatic moiety.
Compounds that are classified as aromatic are characterized
to be cyclic, having conjugated double bonds with delocalized
electrons. Aromatic compounds exhibit unusual stability. This
gain in stability is due to resonance energy and is the result of the
delocalized and overlapping orbitals of the p electrons. With the
annulated aromatic naphthalene moiety of the pentatrienylligand
in 4¢AR, we hoped that the complex would be blocked from the
undesired cyclization, i.e. 6¢AR, and facilitate migration to form
the preferred iron complex J.8 (See Scheme 5.) Such would be
true if the energy required to break the arornaticity of the ring was
too much to allow cyclization to occur. Our synthesized
pentatrienyl complex would then possess DNA alkylation
potential.

Methods:
The experimental design consisted of beginning with the
applicable 1-bromo-2-methylnaphthalene (7) and performing a
series of reactions to synthesize the desired :~:?-naphthalene
annulated pentatrienyl quinone methide complexes. The series
of reactions are shown in Scheme 6.
Step
1:
Preparation
of
1-Bromo-2bromomethylnaphthalene (8 ). A round-bottomed flask equipped

with a magnetic stir bar was fitted with an air condenser. The
bromo-methylnaphthalene 7 (19mL, 122mmol), NBS (24.175g,
160.75mmol), and 500mL ofCC14 were placed inside the flask
and irradiated with a 250W flood lamp for 20h while stirring. The
product was recrystallized in hot hexanes to give a mass product
8 of26.095g in 71.3% yield.
https://scholarworks.uark.edu/inquiry/vol3/iss1/18
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Step
2:
Preparation
of
1-Bromo-2hydroxymethylnaphthalene (9). A round-bottomed flask was

equipped with a magnetic stir bar, and complex 8 (26.095g,
86.98mmol), CaC03 (44.784g, 447.84mmol), 250mL of
deionized water, and 250mL of P-dioxane were added. The
reaction was refluxed at 90"C for 16h while stirring. The solution
was then allowed to cool. The organic product was collected by
being dissolved in 600mL of CH2Cl 2 and 800mL of IM HCI.
After separation, the organic phase was washed three times with
IOOmL portions of saturated NaHC0 3 and dried over MgS04•
The product was recrystallized in hot hexanes to give a mass
product 9 of 9.08g in 44% yield.
Step 3: Preparation of 1-Bromo-2-carbaldehyde
naphthalene (10 ). Complex 9 (6.5g, 27 .3mmol) was dissolved in

180mL of CH2Cl2• In a round-bottomed flask, PCC (11.75g,
54.4mmol), the naphthalene solution, and a stir bar were placed.
The reaction flask was fitted with an air condenser and allowed
to stir for 1.5h. Ether (40mL) was added to the reaction mixture,
and the black gum was washed with two IOmL portions of ether.
This organic phase was passed through a column of a 1-in.layer
of celite wet with ether. The product was purified over a column
of silica gel in 10% ether/pentane solution. The mass product 10
was 5.907g in 92%yield.
Step 4: Preparation ofAcetic acid 1-(2-bromonaphthalen1-yl)hept-2-ynyl ester (11). In a large oven-dried Schlenk tube,

a magnetic stir bar was added, and N2 atmosphere was established.
Dry ether (75mL) and 1-hexyne (lmL, 8.8mmol) were added.
The reaction flask was submerged in an ice bath. N-BuLi ( l.6M,
5.5mL, 8.8mmol) was added dropwise over a period of 5min.
The solution was allowed to stir IOmin. In a small oven-dried
Schlenk tube of N2 atmosphere, complex 10 ( l.872g, Smmol)
was quickly added, and the flask was degassed three times. The
aldehyde was dissolved in 85mL of dry ether. The aldehyde
solution was added to the reaction mixture over a period of
1Omin, and it was allowed to stir for 1.5h. After having warmed
to room temperature, to the reaction flask was added lOOmL of
ether and 75mL of DI H,O. After separation, the organic was
washed twice with 75mL portions of DI Hp and dried over
MgSO4 • The product was purified by passing it over silica gel in
ether. The mass product 11 was 2.562g in 89% yield.
Step 5: Preparation of 2-Bromo-1-(3-meth_ylhepta-1,2dienyl)naphtha/ene (12). In a large oven-dried Schlenk tube, a

magnetic stir bar was added and N, atmosphere was established.
Quickly, LiBr (2.345g, 27mmol) and Cui (5.142g, 27mmol)
were added to the flask. The flask was degassed three times. The
reagents were dissolved in 90mL of dry ether and allowed to stir
30min in an ice bath. MeMgBr (3M, 9mL, 27mmol) was added
dropwise over a period of 5min. The reaction was stirred 30min.
In a small oven-dried Schlenk tube ofN, atmosphere, complex
11 (3.2g, 8.9mmol) was added and dissolved in 25mL of dry
ether. This solution was added dropwise to the reaction mixture
over a period of 5min, the ice bath was removed, and the solution
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was allowed to stir for 24h. To extract the compound, 40mL of
DI Hp and 50mL of ether was added to the Schlenk tube. The
solution was filtered over a B,chner funnel. After the addition of
50mL of ether and 30mL of saturated NH4Cl, the filtrate was
separated. The organic phase was washed three times with 30mL
portions of DI Hp and dried over MgS04 • The product was
purified by passing it through silica gel in 2% ether/pentane
solution. The mass product 12 was 1.828g in 65% yield.

Step 6: Preparation of I}-Pentatrienyl Sigma Complex
(13 ). To a medium oven-dried Schlenk tube, a magnetic stir bar
was added and N 2 atmosphere was established. Dry THF (20mL)
and complex 12 (l.008g, 3.2mmol) were added to the Schlenk
tube. The tube was placed in an acetone/dry ice bath at -88=C.
It was allowed to stir I Omin. Over a period of 5min, 1.6M n-BuLi
(2.2mL, 3.52mmol) was added. The solution was allowed to stir
for I h. In a small oven-dried Schlenk tube of N 2 atmosphere,
quickly Fpi (0.623g, 3.52mmol) was added, and after a N2
atmosphere had been re-established, the crystals were dissolved
in 8mL of dry THF. Over a period of I Omin, the Fpi solution was
added to the medium Schlenk tube. After stirring I Omin, the ice
bath was removed, and stirring was continued for an additional
20min. The reaction mixture was coated with 8.8g of 6% water/
alumina gel. It was immediately transferred to the top of a N 2
saturated 6% water/alumina column, keeping in mind that this
product is unstable in the presence of air. The product was eluted
at a rate of one drip per second with 2.5% ether/pentane solution.
The mass product 13 was 0.8I4g with a 62% yield.

'•

Conversion of 2/-Pentatrienyl Sigma Complex to 5MemberedRing Quinone Methide Complexes(l4). Complex 13
was thermodynamically converted to 14 by placing it in a dry
flask in dark atmosphere over a period of two weeks. This
quinone methide complex was purified by passing it through aN2
saturated 6% water/alumina column with 2.5% ether/pentane
solution. Two bands were present with remnants of complex 13
eluting first off the column followed by the complex 14.
Al!..ylation Reactions. Fours mall aliquots of the 5-membered
ring quinone methide complexes were dissolved in I.5mL of
CDCI 3 and placed in a NMR tube. IOmL (10 equivalents) of
diethylamine, 5mL (4 equivalents) of ethanol, 20mL (20
equivalents) of methanol, and I OmL( I Oequivalents) of methanol
were placed in the tubes, respectively. The first three tubes were
placed in an ice bath of O"C, and the last tube was placed in a dry
ice/acetone bath of -78°C.AII reactions were photolyzedat75W.
These reactions were monitored through Nuclear Magnetic
Resonance. See Figures 4, 5, 6, and 7 for results.

Results and Discussion:
Preparation of the desired h 3-naphthalene annulated
pentatrienyl quinone methide analog was successfully
accomplished as shown in Scheme 6. Reaction of I-bromo-2carbadehyde naphthalene (10) with hexynyllithium followed by
acylation gave 11 in an 89% yield. Reaction of 11 with Cui I
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MeMgBr yielded the allene 12 in 65% yield. Reaction of the
naphthalene annulated vinyl allene bromide 12 with n-BuLi
followed by (C5H5)Fe(C0) 2I gave sigma complex 13 in 62%
yield. This h 1-sigma complex is identified through 1H-NMR by
its characteristic peaks at d 6.76 and d 5.08. The absorption at d
6.76 has an integration of I, resulting from the single proton on
the allene, and the peak at d 5.08 has an integration of 5, resulting
from the 5 protons on the cyclopentadienyl group. [See Figure

2.]
At room temperature, this compound was cleanly converted
to the diasterometric stable quinone methide complexes 14 with
a half-life of two weeks. The compound is identified through 1HNMR by characteristic peaks at d 4.I2 and d 3.52, 3.58. The
former allene peak at d 6. 7 6 had disappeared, and two new peaks
had appeared at ca. d 3.5 with an integration of I; this represents
the single proton on the h3-complex. Also, the peak at d 5.08 had
shifted to d 4.12, representing the 5 protons on the
cyclopentadienyl group. [See Figure 3.]
Initial alkylation reactions were performed to mimic the
quinone methide analog reactions in the presence of cancerous
DNA. The test reagents chosen (diethylamine, ethanol, and
methanol) all represented the characteristics of amine or alcohol
groups contained on DNA. In the process of alkylation, the
quinone methide analog would attach itself to DNA; this reactivity
is a key factor in the nature of an anticancer drug. The results of
the four reactions (Figures 4, 5, 6, and 7) reveal that there were
definite changes in the course of the reactions as compared to the
1
H-NMR spectrum of the quinone analog starting complex
(Figure 3). In all four reactions, a set of twin novel peaks are
formed at d 6.45, 6.55. However, more tests must be done on the
products of the alkylation reactions to accurately determine what
is exactly happening, ifDNA alkylation is indeed occurring, and
what is being formed.
One can note that when comparing the methanol reactions
at 0 and -78°C (Figures 6 and 7) the ideal condition for photolysis
is in a dry ice/propanol solution of -78°C. Here, the reaction was
much cleaner and would better facilitate identification of the
newly formed products. This alkylation reaction with methanol
at -78°C was recently submitted for analysis via Electrospray
Mass Spectroscopy. However, there has not been sufficient time
to thoroughly analyze the results and begin the process of
identifying the products of the alkylation reaction.
Indefinitely, this research project has provided a strong
foundation in the chemistry of transition metal pentatrienyl
complexed 5-membered ring quinone methide analog. It has
proven successful in the synthesis of the desired complex. Thus,
we have made a contributable step toward the potential of an
anticancerous drug. With a promising future, we can continue in
further research to study alkylation reactions with this newly
synthesized product.
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Faculty Comments:
Neil Allison. Ms. Means' faculty mentor, is lavish in his
praise of her work. He says:
Mv contact with Ms. Means has been extensive. First
sh~ attended my organic chemistry lab course (Organic
1, CHEM 3702) that I taught in fall1999. In the spring
2000, she was enrolled in my organic chemistry lecture
course (Organic 11, CHEM 3713). At this time she
decided to carry out honors research work in my
group. Ms. Means is currently working in my research
lab on a chemistry problem that focuses on model
studies of potential anticancer and anti-tumor drugs.
She has chosen to carry out these studies as her senior
honor's project in her four-year honors scholar
program. This course of study is themostacadernically
rigorous program on our campus. I would say that
she is truly a multi-task person that solves all problems
with gusto. Even with all of her obligations, I have
found that Ms. Means is not a "bookworm" type. She
is completely honest and reliable. She has an amiable
personality and is well liked by our faculty and her
peers. Probably most impressive on the research front
is that she also is a leader in my laboratory. When she
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is present, all of the students are excited about their
research! This rare quality is not found in many
people, and to have a person that is excited about
research with an effervescent personality really tends
to ignite the whole lab.The research that Ms. Means is
currentlyaccomplishingis comparable to what I would
expect from a good third-year graduate student. She
grasps theoretical chemical concepts instantly. In fact,
after she read a grant proposal that I was writing in
the area of her research, she was able to offer
suggestions! I would never have expected this from
an undergraduate student and only would expect a
third or fourth year graduate student to be mature
enough for this task. Her laboratory skills are the best
I've seen from any undergraduate student (and most
graduate students) in my laboratory. She has
accomplished a completed project, one that I am
currently writing up as a communication for
publicationinanAmericanChernicalSocietyjournal.
To be published as a communication means that it
must be "urgent, fast breaking research". In this paper
wereportthatshehasaccomplishedanewmulti-step
synthesis of a previously unknown compound. We
anticipate that this compound will be an important
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model for a new class of drugs based on an
organometallic system (something previously
unknown). All factors considered, of our current
chemistry students I would rank Ms. Means at the top
in research. Before corning to this university I studied
at the UniversityofCalifornia, Berkeley, the University
of Cologne, and the University of Florida, Gainesville.
I would rank Ms. Means, at her stage in her career,
among the best undergraduate students that I've seen
at these universities. Over the past 22 years, I've
probably written 160 or so letters of recommendation
for students, half of whom I would consider as
outstanding students. Ms. Means is certainly in the
very top handful (3 to 5) of these students.
I must also mention, although not related to research,
that Ms. Means also takes on other, perhaps more
mature,responsibilities.Throughhercompellingneed
to help people she is carrying out missionary work in
a very impoverished area of Haiti for two months this
summer and during spring break. Traci is active in
helping people. I just found out that she purchases
food for an elderly woman who is housebound and
takes it to her apartment. In the past Ms. Means has
also helped visually impaired students. This includes
note taking, reading, etc.

Ms. Means' faculty advisor, Dale Johnson, is also very
complimentary; hi remarks follow ...
I have been Traci Means' academic advisor for the
past four years so I am familiarwithher great academic
strengths, and I have followed her research through
conversation with Ms. Means and her mentor Professor
Allison. Ms. Means is a special student; she is quick to
grasp concepts and can use them in new situations
with ease. She has never chosen the easy academic
path and is completing the four-year honors degree
leading to a BS in Biophysical Chemistry, perhaps the
most demanding undergraduate degree option offered
by the Department of Chemistry and Biochemistry. In
her own words, "I chose this rigorous major because
I believe it is interesting, challenging, and will best
prepare me for my next academic goal, entering
medical schooL"
Professor Neil Allison has raved about her work ethic
and the ease with which she learns laboratory skills.
Despite a busy academic schedule, she is the most
productivememberofhisresearchgroup,surpassing
the output of some of our graduate students. I have
read a draft of a publication that is in progress based

onherundergraduate thesis.
It will be an important
contribution to both
organometallic
and
biosynthetic ch.e mistry and
will serve as the foundation
for a new research direction
for Allison's research group.
This is the sort of
contribution you hope will
come from the efforts of an
excellent graduate student.
To see this productivity from
an undergraduate is
extremely impressive.
A thjrd chemjstry profes or, Wally Cordes,
enthu iastic about Ms. Mean ' research. He says ...

equally

It is easy to say positive things aboutTraci Means. The
expectations of the chemistry department are high;
even so, the research independence developed by Ms.
Means is extraordinary, and her over-all academic
record is equally outstanding.
Professor Allison has had a large number of excellent
undergraduate students work in his lab during his
tenure here, and for him to say that Ms. Means is
about the besthehasever had is a significantstatement.
The research she has done is not a trivial project: the
extremely air-sensitive rna terials she has worked with
require the highest level of experimental technique.
And the chemical reactions she has developed and
perfected are all very sophisticated organic reactions.
In reading the abstract of her work I can see how Dr.
Allisoncomparesittotheworkofathird-yeargraduate
student. Organic synthesis is not an easy kind of
research for an undergraduate student to pursue; it
requires more patience and perseverance than many
other kinds of chemical research. There are many
minor details that must be handled to have decent
yields of final products. In most cases of an
undergraduate student doing this kind of research
one expects the student to make daily visits to the
research director asking foradviceonhow to overcome
"the problem of the day". That's whyitalso impresses
me when Dr. Allison said Ms. Means would go to the
lab and attack these problems on her own, so that by
the next time he saw her she would tell him how she
had solved the problems and attained the desired
results.
The research will be submitted for publication in one
of the highest prestige research journals of the
American Otemical Society, and I'm confident it will
be published. In addition to the organic chemistry
developed, it has important pertinence to the "hot"
area of research for selective drug delivery.
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